Private Equity

Liquidity Events

InvAscent exits animal health co. Intron; deal value estimated at $25-M

Investor Announcement   Intron Life Sciences  

Healthcare-focused private equity investor InvaScent has made a complete exit from Hyderabad-based animal health company Intron Life Sciences . The deal value is learnt to be about USD 25 million.Veda Corporate Advisors were the advisors to Invascent, Intron and its promoters on the deal. Other advisors to the deal included Quillon Partners and Deloitte.Intron is one of the largest homegrown animal health companies with a leadership position in animal probiotics and a presence across 8 countries.

In Dec-2018, Invascent had invested INR 70 Cr in Intron.